Healthcare - Sector
ALLO is currently covered by 7 analysts with an average price target of $7.57. This is a potential upside of $6.94 (1101.59%) from yesterday's end of day stock price of $0.63.
Our record on ALLO covers 24 analysts since 2008; 7 cover it today. Of the 137 price targets those analysts set on ALLO, 31 were reached (23%). The highest performance score on ALLO belongs to Biren Amin of Piper Sandler: 11.06, with 2 of 10 targets met in 3 days on average. The latest calls: Reni Benjamin of JMP raised the target to $6 from $5 with a Buy rating on 17 Aug 2026; Roger Song of Jefferies kept the target at $10 with a Buy rating on 22 Apr 2026; Brian Cheng of JPMorgan updated the call with a Sell rating on 16 Apr 2026. Figures as of 18 Nov 2026.
Allogene Therapeutics's activity chart (see below) currently has 176 price targets and 164 ratings on display. The stock rating distribution of ALLO is 66.67% BUY, 22.22% HOLD and 11.11% SELL.
Analysts' price targets on this stock were met 25.48% of the time, taking 85.57 days on average.
Highest price target for ALLO is $11, Lowest price target is $3.85, average price target is $7.57.
Most recent stock forecast was given by RENI BENJAMIN from JMP on 17-Aug-2026. First documented stock forecast 05-Nov-2018.
Currently out of the existing stock ratings of ALLO, 2 are a HOLD (22.22%), 6 are a BUY (66.67%), 1 are a SELL (11.11%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Aug-2026
$6
$4.96 (476.92%)
$5
3 months 4 days ago
(17-Aug-2026)
1/10 (10%)
$3.92 (188.46%)
148
Sell Since 16-Apr-2026
7 months 5 days ago
(16-Apr-2026)
0/3 (0%)
$2.86 (55.64%)
Buy Since 04-Apr-2023
$11
$9.96 (957.69%)
$12
7 months 5 days ago
(16-Apr-2026)
0/12 (0%)
$8.63 (364.14%)
Hold Since 21-Mar-2023
$3.85
$2.81 (270.19%)
$6
7 months 7 days ago
(14-Apr-2026)
1/2 (50%)
$1.57 (68.86%)
44
Buy Since 14-May-2025
$9
$7.96 (765.38%)
$9
7 months 7 days ago
(14-Apr-2026)
1/4 (25%)
$6.72 (294.74%)
19
What is ALLO (Allogene Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on ALLO (Allogene Therapeutics)?
Which analyst has the most public recommendations on ALLO (Allogene Therapeutics)?
Which analyst is the currently most bullish on ALLO (Allogene Therapeutics)?
Which analyst is the currently most reserved on ALLO (Allogene Therapeutics)?